Pharmaceutical
companies Gilead and Merck announced Friday that they
would distribute Atripla--the FDA-approved once-daily
HIV pill--to developing countries around the
world.
"The FDA's rapid
review and approval of Atripla will help to expedite
access for adults infected with HIV-1 living in
resource-limited parts of the world," said John
Martin, Gilead's president and CEO.
The companies
didn't specify which nations would receive the drug. Only
one in five people in need of HIV treatment in low- and
middle-income countries were receiving it by the end
of 2005. (The Advocate)
Charlie Kirk DID say stoning gay people was the 'perfect law' — and these other heinous quotes